Key result
Exogenous Ang-1 reduces BBB leakage and improves neurological function in rats after subarachnoid hemorrhage.
Why the study?
Subarachnoid hemorrhage disrupts microvascular endothelial integrity and blood-brain barrier function, with unclear dynamics of Angiopoietin-1 and Angiopoietin-2 expression after SAH.
Does exogenous Ang-1 injection reduce blood-brain barrier leakage and improve neurological function in a rat model of subarachnoid hemorrhage?
Does exogenous Ang-1 injection reduce blood-brain barrier leakage and improve neurological function in a rat model of subarachnoid hemorrhage?
Answers are grounded in this paper and cite their sources.
In a rat model of subarachnoid hemorrhage, exogenous Angiopoietin-1 restores the Ang-1/Ang-2 balance, reducing blood-brain barrier disruption and improving neurological outcomes.
PURPOSE: Microvascular endothelial integrity is important for maintaining the blood-brain barrier (BBB). However, subarachnoid hemorrhage (SAH) disrupts this integrity, making the BBB dysfunctional-an important pathophysiological change after SAH. Angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) regulate microvascular permeability by balancing each other's expression. METHODS: This study investigated the dynamics of Ang-1 and Ang-2 expression after SAH and the protective effect of Ang-1 on BBB functioning using an endovascular puncture model of rat SAH. The Ang-1 and Ang-2 expression in brain tissue was determined by immunohistochemistry. In addition, Western blotting was used to estimate Ang-1 and Ang-2 concentration and to compare them at 6-72 hours post-SAH cortex and hippocampus. Evans blue viability assay was used to evaluate BBB permeability, and neurological testing was implemented to evaluate neurological impairment during SAH. RESULTS: It was found that following SAH, Ang-1 expression decreases and Ang-2 expression increases in the cortex, hippocampus, and microvessels. The Ang-1/Ang-2 ratio decreased as quickly as 6 hours after SAH and reached its lowest 1 day after SAH. Finally, it was found that exogenous Ang-1 reduces SAH-associated BBB leakage and improves neurological function in post-SAH rats. CONCLUSIONS: Our findings suggest that the equilibrium between Ang-1 and Ang-2 is broken in a period shortly after SAH, and the treatment of exogenous Ang-1 injection alleviates neurological dysfunctions through decreasing BBB destruction.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2016) studied Subarachnoid hemorrhage (n=150). Angiopoietin-1 (Ang-1) peptide vs. Vehicle was evaluated on Blood-brain barrier permeability (Evans blue extravasation) and neurological scores (p=<0.05). Exogenous Angiopoietin-1 treatment significantly reduced blood-brain barrier leakage and improved neurological function in rats following subarachnoid hemorrhage.
Synapse has enriched 10 related papers. Consider them for comparative context: